Advertisement

Journal of Clinical Immunology

, Volume 25, Issue 1, pp 41–49 | Cite as

Expression of the CD7 Ligand K-12 in Human Thymic Epithelial Cells: Regulation by IFN-γ

  • Gordon K. Lam
  • Hua-Xin Liao
  • Yan Xue
  • S. Munir Alam
  • Richard M. Scearce
  • Russel E. Kaufman
  • Gregory D. Sempowski
  • Barton F. Haynes
Article

Abstract

CD7 is an immunoglobulin superfamily molecule expressed on T, NK, and pre-B lymphocytes. Previous studies have demonstrated a role for CD7 in T- and NK-cell activation and cytokine production. Recently, an epithelial cell secreted protein, K12, was identified as a CD7 ligand. Although CD7 is expressed intrathymically, it is not known if K12 is produced in human thymus. To determine roles that K12 might play in the human thymus, we analyzed expression of K12 in human thymocytes, thymic epithelial cells (TE), and thymic fibroblasts. We found that recombinant human K12 bound strongly to soluble hCD7, with a Keq of 37.6×10–9M, and this interaction was inhibited by a novel antihuman K12 monoclonal antibody (K12-A1). K12 mRNA was detected by RT–PCR and northern analysis in human TE and thymic fibroblasts, but not in human thymocytes. Expression of K12 in TE cells was upregulated by IFN-γ . Taken together, these data demonstrated that K12 is produced by human TE cells and thymic fibroblasts, and is regulated in thymus by IFN-γ . These data suggest a role for thymic microenvironment-produced K12 in regulation of thymocyte signaling and cytokine release, particularly in the setting of thymus pathology where IFN-γ is upregulated such as myasthenia gravis.

Keywords

Human CD7 K12 thymic epithelial cells 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Sempowski GD, Lee DM, Kaufman RE, Haynes BF: Structure and function of the CD7 molecule. Crit Rev Immunol 19:331–348, 1999Google Scholar
  2. 2.
    Jung LK, Roy AK, Chakkalath HR: CD7 augments T cell proliferation via the interleukin-2 autocrine pathway. Cell Immunol 141:189–199, 1992Google Scholar
  3. 3.
    Carrel S, Salvi S, Rafti F, Favrot M, Rapin C, Sekaly RP: Direct involvement of CD7 (gp40) in activation of TcR gamma/delta+ T cells. Eur J Immunol 21:1195–1200, 1991Google Scholar
  4. 4.
    Rabinowich H, Pricop L, Herberman RB, Whiteside TL: Expression and function of CD7 molecule on human natural killer cells. J Immunol 152:517–526, 1994Google Scholar
  5. 5.
    Sempowski GD, Lee DM, Scearce RM, Patel DD, Haynes BF: Resistance of CD7-deficient mice to lipopolysaccharide-induced shock syndromes. J Exp Med 189:1011–1016, 1999Google Scholar
  6. 6.
    Sempowski GD, Cross SJ, Heinly CS, Scearce RM, Haynes BF: CD7 and CD28 are required for murine CD4(+)CD25(+) regulatory T cell homeostasis and prevention of thyroiditis. J Immunol 172:787–794, 2004Google Scholar
  7. 7.
    Heinly CS, Sempowski GD, Lee DM, Patel DD, McDermott PM, Scearce RM, et al.: Comparison of thymocyte development and cytokine production in CD7-deficient, CD28-deficient and CD7/CD28 double-deficient mice. Int Immunol 13:157–166, 2001Google Scholar
  8. 8.
    Slentz-Kesler KA, Hale LP, Kaufman RE: Identification and characterization of K12 (SECTM1), a novel human gene that encodes a golgi-associated protein with transmembrane and secreted isoforms. Genomics 47:327–340, 1998Google Scholar
  9. 9.
    Lyman SD, Escobar S, Rousseau AM, Armstrong A, Fanslow WC: Identification of CD7 as a cognate of the human K12 (SECTM1) protein. J Biol Chem 275:3431–3437, 2000Google Scholar
  10. 10.
    Miralles GD, Smith CA, Whichard LP, Morse MA, Haynes BF, Patel DD: CD34+CD38-lin- cord blood cells develop into dendritic cells in human thymic stromal monolayers and thymic nodules. J Immunol 160:3290–3298, 1998Google Scholar
  11. 11.
    Aruffo A, Seed B: Molecular cloning of two CD7 (T-cell leukemia antigen) cDNAs by a COS cell expression system. EMBO J 6:3313–3316, 1987Google Scholar
  12. 12.
    Alam SM, Travers PJ, Wung JL, Nasholds W, Redpath S, Jameson SC, et al.: T-cell-receptor affinity and thymocyte positive selection.[see comment]. Nature 381:616–620, 1996Google Scholar
  13. 13.
    Scearce RM, Eisenbarth GS: Production of monoclonal antibodies reacting with the cytoplasm and surface of differentiated cells. In Methods in Enzymology, Vol 103, Conn PH (ed). Academic Press, 1983, p. 459Google Scholar
  14. 14.
    Jung LK, Fu SM, Hara T, Kapoor N, Good RA: Defective expression of T cell-associated glycoprotein in severe combined immunodeficiency. J Clin Invest 77:940–946, 1986Google Scholar
  15. 15.
    Sempowski GD, Hale LP, Sundy JS, Massey JM, Koup RA, Douek DC, et al.: Leukemia inhibitory factor, oncostatin M, IL-6, and stem cell factor mRNA expression in human thymus increases with age and is associated with thymic atrophy. J Immunol 164:2180–2187, 2000Google Scholar
  16. 16.
    Haynes BF, Markert ML, Sempowski GD, Patel DD, Hale LP: The role of the thymus in immune reconstitution in aging, bone marrow transplantation, and HIV-1 infection. Ann Rev Immunol 18:529–560, 2000Google Scholar
  17. 17.
    Sempowski GD, Haynes BF: Immune reconstitution in patients with HIV infection. Annu Rev Med 53:269–284, 2002Google Scholar
  18. 18.
    Hashimoto W, Takeda K, Anzai R, Ogasawara K, Sakihara H, Sugiura K, et al.: Cytotoxic NK1.1 Ag+ alpha beta T cells with intermediate TCR induced in the liver of mice by IL-12. J Immunol 154:4333–4340, 1995Google Scholar
  19. 19.
    Ogasawara K, Takeda K, Hashimoto W, Satoh M, Okuyama R, Yanai N, et al.: Involvement of NK1+ T cells and their IFN-gamma production in the generalized Shwartzman reaction. J Immunol 160:3522–3527, 1998Google Scholar
  20. 20.
    Seki S, Abo T, Ohteki T, Sugiura K, Kumagai K: Unusual alpha beta-T cells expanded in autoimmune lpr mice are probably a counterpart of normal T cells in the liver. J Immunol 147:1214–1221, 1991Google Scholar
  21. 21.
    Takahashi M, Ogasawara K, Takeda K, Hashimoto W, Sakihara H, Kumagai K, et al.: LPS induces NK1.1+ alpha beta T cells with potent cytotoxicity in the liver of mice via production of IL-12 from Kupffer cells. J Immunol 156:2436–2442, 1996Google Scholar
  22. 22.
    Lee DM, Staats HF, Sundy JS, Patel DD, Sempowski GD, Scearce RM, et al.: Immunologic characterization of CD7-deficient mice. J Immunol 160:5749–5756, 1998Google Scholar

Copyright information

© Springer Science + Business Media, Inc. 2005

Authors and Affiliations

  • Gordon K. Lam
    • 1
  • Hua-Xin Liao
    • 1
  • Yan Xue
    • 1
  • S. Munir Alam
    • 1
  • Richard M. Scearce
    • 1
  • Russel E. Kaufman
    • 1
  • Gregory D. Sempowski
    • 1
  • Barton F. Haynes
    • 1
    • 2
    • 3
  1. 1.Department of MedicineDuke Human Vaccine Institute, Duke University School of MedicineDurham
  2. 2.Department of ImmunologyDuke Human Vaccine Institute, Duke University School of MedicineDurham
  3. 3.Duke HospitalNorth Durham

Personalised recommendations